Immune cell therapy tested in fight against tough testicular cancers
NCT ID NCT05634785
Summary
This study tested a personalized immune cell therapy for adults with a hard-to-treat type of testicular cancer that had come back or worsened after standard treatments. Doctors collected and modified a patient's own immune cells (T cells) to better target and attack cancer cells. The main goals were to see if the treatment could shrink tumors and to learn how long these modified cells survived in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.